T1	Participants 478 577	50 samples from Swiss and North American infants with correlative hormonal data were also genotyped
T2	Participants 365 468	603 randomly chosen New Zealand neonates were genotyped blind to 17-hydroxyprogesterone (17-OHP) levels
